 Mary Coussons-Read
Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aggression | 6 | 2016 | 185 | 1.950 |
Why?
| | Interleukin-6 | 11 | 2019 | 677 | 1.490 |
Why?
| | C-Reactive Protein | 7 | 2016 | 364 | 1.290 |
Why?
| | Pregnancy Complications | 5 | 2022 | 431 | 1.120 |
Why?
| | Anxiety | 5 | 2023 | 854 | 1.110 |
Why?
| | Personality Disorders | 4 | 2019 | 68 | 1.080 |
Why?
| | Postpartum Period | 5 | 2021 | 281 | 1.020 |
Why?
| | Inflammation | 7 | 2021 | 2500 | 0.950 |
Why?
| | Pregnancy | 22 | 2023 | 5550 | 0.940 |
Why?
| | Stress, Psychological | 6 | 2022 | 975 | 0.760 |
Why?
| | Depression, Postpartum | 2 | 2021 | 102 | 0.720 |
Why?
| | Sleep Initiation and Maintenance Disorders | 2 | 2021 | 116 | 0.720 |
Why?
| | Hydrocortisone | 6 | 2023 | 273 | 0.690 |
Why?
| | Kynurenine | 2 | 2019 | 80 | 0.680 |
Why?
| | Cytokines | 5 | 2015 | 1853 | 0.680 |
Why?
| | Depression | 5 | 2022 | 1147 | 0.660 |
Why?
| | Biomarkers | 6 | 2021 | 3468 | 0.660 |
Why?
| | Premature Birth | 3 | 2023 | 278 | 0.640 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2012 | 1137 | 0.590 |
Why?
| | Pregnancy Trimesters | 2 | 2006 | 13 | 0.560 |
Why?
| | Morphine | 5 | 1999 | 124 | 0.540 |
Why?
| | Pregnant Women | 2 | 2016 | 132 | 0.530 |
Why?
| | Receptors, Interleukin-1 Type II | 1 | 2015 | 6 | 0.500 |
Why?
| | Tryptophan | 1 | 2016 | 136 | 0.500 |
Why?
| | Disruptive, Impulse Control, and Conduct Disorders | 2 | 2016 | 9 | 0.500 |
Why?
| | Health Status Indicators | 1 | 2013 | 155 | 0.420 |
Why?
| | Inflammation Mediators | 2 | 2013 | 479 | 0.420 |
Why?
| | Gestational Age | 4 | 2021 | 758 | 0.410 |
Why?
| | Adjuvants, Immunologic | 2 | 2008 | 206 | 0.410 |
Why?
| | Sleep Deprivation | 2 | 2021 | 166 | 0.400 |
Why?
| | Adult | 24 | 2021 | 30726 | 0.400 |
Why?
| | Corticotropin-Releasing Hormone | 2 | 2022 | 78 | 0.400 |
Why?
| | Adaptation, Psychological | 2 | 2013 | 551 | 0.390 |
Why?
| | Female | 33 | 2023 | 59932 | 0.390 |
Why?
| | Social Support | 3 | 2016 | 539 | 0.360 |
Why?
| | Lymphocytes | 3 | 2008 | 344 | 0.350 |
Why?
| | Self Report | 1 | 2013 | 698 | 0.340 |
Why?
| | Psychiatric Status Rating Scales | 3 | 2018 | 485 | 0.340 |
Why?
| | Pregnancy Trimester, Third | 3 | 2022 | 77 | 0.330 |
Why?
| | Sleep | 3 | 2021 | 625 | 0.330 |
Why?
| | Circadian Rhythm | 3 | 2023 | 371 | 0.320 |
Why?
| | Agricultural Workers' Diseases | 1 | 2009 | 23 | 0.320 |
Why?
| | Animal Husbandry | 1 | 2009 | 33 | 0.320 |
Why?
| | Epigenesis, Genetic | 3 | 2021 | 526 | 0.310 |
Why?
| | Xylans | 1 | 2008 | 3 | 0.310 |
Why?
| | Shiitake Mushrooms | 1 | 2008 | 2 | 0.310 |
Why?
| | Orthomyxoviridae Infections | 2 | 1999 | 55 | 0.300 |
Why?
| | Health Behavior | 1 | 2013 | 707 | 0.300 |
Why?
| | Oryza | 1 | 2008 | 20 | 0.300 |
Why?
| | Sleep Wake Disorders | 2 | 2008 | 233 | 0.300 |
Why?
| | Young Adult | 12 | 2021 | 10487 | 0.290 |
Why?
| | Anxiety Disorders | 4 | 2022 | 310 | 0.280 |
Why?
| | Humans | 34 | 2023 | 115613 | 0.270 |
Why?
| | Seasons | 1 | 2009 | 449 | 0.270 |
Why?
| | Aging | 3 | 2021 | 1631 | 0.270 |
Why?
| | Pregnancy Trimester, First | 2 | 2022 | 127 | 0.270 |
Why?
| | Plant Extracts | 1 | 2008 | 153 | 0.270 |
Why?
| | Lymphocyte Activation | 5 | 2008 | 1057 | 0.260 |
Why?
| | Impulsive Behavior | 3 | 2016 | 109 | 0.260 |
Why?
| | Rats, Inbred Lew | 7 | 2008 | 93 | 0.250 |
Why?
| | Spinal Puncture | 2 | 2015 | 19 | 0.240 |
Why?
| | Neuroimmunomodulation | 2 | 1995 | 71 | 0.240 |
Why?
| | Leukocytes, Mononuclear | 1 | 2007 | 501 | 0.240 |
Why?
| | Conditioning, Classical | 2 | 1995 | 87 | 0.240 |
Why?
| | Narcolepsy | 1 | 2004 | 19 | 0.240 |
Why?
| | Interferon-gamma | 3 | 2021 | 726 | 0.240 |
Why?
| | Human Growth Hormone | 1 | 2004 | 38 | 0.230 |
Why?
| | Acculturation | 2 | 2016 | 52 | 0.230 |
Why?
| | Mexican Americans | 2 | 2016 | 101 | 0.220 |
Why?
| | Catecholamines | 1 | 2002 | 97 | 0.210 |
Why?
| | Interleukin-2 | 3 | 2008 | 417 | 0.210 |
Why?
| | Chorioamnionitis | 1 | 2021 | 36 | 0.190 |
Why?
| | Personality Inventory | 2 | 2014 | 135 | 0.190 |
Why?
| | Male | 20 | 2020 | 55968 | 0.190 |
Why?
| | Pituitary-Adrenal System | 4 | 2023 | 162 | 0.190 |
Why?
| | Mothers | 3 | 2022 | 666 | 0.190 |
Why?
| | Hypothalamo-Hypophyseal System | 4 | 2023 | 197 | 0.190 |
Why?
| | Killer Cells, Natural | 3 | 2008 | 383 | 0.180 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2022 | 448 | 0.180 |
Why?
| | Pregnancy Outcome | 3 | 2021 | 337 | 0.180 |
Why?
| | Picolinic Acids | 2 | 2019 | 3 | 0.180 |
Why?
| | Longitudinal Studies | 4 | 2021 | 2420 | 0.180 |
Why?
| | Maternal Behavior | 1 | 2020 | 70 | 0.170 |
Why?
| | Interleukins | 1 | 2021 | 238 | 0.170 |
Why?
| | Receptors, Cannabinoid | 1 | 2019 | 14 | 0.170 |
Why?
| | Placenta | 2 | 2022 | 624 | 0.170 |
Why?
| | Endocannabinoids | 1 | 2019 | 37 | 0.170 |
Why?
| | Birth Weight | 2 | 2020 | 439 | 0.170 |
Why?
| | Middle Aged | 9 | 2021 | 27014 | 0.160 |
Why?
| | Altitude | 1 | 2002 | 409 | 0.160 |
Why?
| | Psychometrics | 2 | 2014 | 615 | 0.150 |
Why?
| | Influenza A virus | 1 | 1999 | 91 | 0.150 |
Why?
| | Personality | 1 | 2019 | 114 | 0.150 |
Why?
| | Prenatal Care | 1 | 2020 | 257 | 0.150 |
Why?
| | Orthomyxoviridae | 1 | 1998 | 35 | 0.150 |
Why?
| | Diabetes, Gestational | 1 | 2021 | 282 | 0.150 |
Why?
| | Saliva | 3 | 2023 | 189 | 0.140 |
Why?
| | Infant | 4 | 2022 | 7976 | 0.140 |
Why?
| | Mental Health | 1 | 2022 | 571 | 0.140 |
Why?
| | Rats | 7 | 2008 | 5034 | 0.140 |
Why?
| | Quinolinic Acid | 1 | 2016 | 7 | 0.140 |
Why?
| | Kynurenic Acid | 1 | 2016 | 10 | 0.140 |
Why?
| | Child Development | 1 | 2020 | 389 | 0.130 |
Why?
| | Toxoplasmosis | 1 | 2016 | 31 | 0.130 |
Why?
| | Maze Learning | 1 | 1996 | 87 | 0.130 |
Why?
| | Adult Survivors of Child Abuse | 1 | 2015 | 20 | 0.130 |
Why?
| | Exploratory Behavior | 1 | 1996 | 86 | 0.130 |
Why?
| | Anti-Inflammatory Agents | 1 | 1999 | 448 | 0.130 |
Why?
| | Depressive Disorder | 1 | 2018 | 336 | 0.130 |
Why?
| | Pregnancy Trimester, Second | 2 | 2022 | 66 | 0.120 |
Why?
| | Receptors, Opioid | 1 | 1994 | 19 | 0.120 |
Why?
| | Nadolol | 1 | 1994 | 5 | 0.120 |
Why?
| | Reference Values | 2 | 2008 | 744 | 0.120 |
Why?
| | Receptors, Adrenergic, beta | 2 | 1994 | 133 | 0.120 |
Why?
| | Pilot Projects | 2 | 2020 | 1377 | 0.120 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2015 | 230 | 0.110 |
Why?
| | Interleukin-10 | 2 | 2006 | 299 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 1999 | 344 | 0.110 |
Why?
| | Statistics as Topic | 1 | 2014 | 299 | 0.110 |
Why?
| | Antibody Formation | 1 | 1994 | 273 | 0.110 |
Why?
| | Models, Genetic | 1 | 1996 | 570 | 0.110 |
Why?
| | Serotonin | 1 | 2015 | 296 | 0.110 |
Why?
| | Mitogens | 2 | 2008 | 58 | 0.100 |
Why?
| | Immunity, Cellular | 1 | 1994 | 262 | 0.100 |
Why?
| | Dopamine | 1 | 2015 | 237 | 0.100 |
Why?
| | Nitric Oxide | 2 | 1994 | 832 | 0.100 |
Why?
| | Macrophages | 3 | 1998 | 1284 | 0.100 |
Why?
| | Motor Activity | 1 | 1996 | 633 | 0.090 |
Why?
| | Down Syndrome | 1 | 1996 | 336 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2016 | 3023 | 0.090 |
Why?
| | Suicidal Ideation | 1 | 2015 | 400 | 0.090 |
Why?
| | Immunosuppressive Agents | 1 | 1994 | 666 | 0.090 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 1805 | 0.090 |
Why?
| | Suicide | 1 | 2016 | 501 | 0.090 |
Why?
| | Oxidative Stress | 1 | 2015 | 1093 | 0.080 |
Why?
| | Adolescent | 5 | 2016 | 17903 | 0.080 |
Why?
| | Lipopolysaccharides | 2 | 2007 | 826 | 0.080 |
Why?
| | Avena | 1 | 2008 | 4 | 0.080 |
Why?
| | Superantigens | 1 | 2008 | 69 | 0.080 |
Why?
| | Enterotoxins | 1 | 2008 | 88 | 0.070 |
Why?
| | Seeds | 1 | 2008 | 75 | 0.070 |
Why?
| | Spleen | 2 | 2008 | 492 | 0.070 |
Why?
| | Bacterial Toxins | 1 | 2008 | 103 | 0.070 |
Why?
| | Animals | 9 | 2008 | 32102 | 0.070 |
Why?
| | Life Change Events | 2 | 2021 | 135 | 0.070 |
Why?
| | Disease Models, Animal | 1 | 1996 | 3580 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2016 | 4438 | 0.060 |
Why?
| | Infant, Newborn | 3 | 2023 | 5060 | 0.060 |
Why?
| | Up-Regulation | 1 | 2007 | 820 | 0.060 |
Why?
| | Sleep Stages | 1 | 2004 | 61 | 0.060 |
Why?
| | Dietary Supplements | 1 | 2008 | 458 | 0.060 |
Why?
| | Serum | 1 | 2004 | 57 | 0.060 |
Why?
| | Chronic Disease | 1 | 2009 | 1598 | 0.050 |
Why?
| | Parturition | 1 | 2023 | 56 | 0.050 |
Why?
| | Psychopathology | 1 | 2022 | 48 | 0.050 |
Why?
| | Self Efficacy | 1 | 2005 | 361 | 0.050 |
Why?
| | Fetal Death | 1 | 2021 | 49 | 0.050 |
Why?
| | Age Factors | 1 | 2009 | 2907 | 0.050 |
Why?
| | Vitamins | 1 | 2022 | 151 | 0.050 |
Why?
| | Optimism | 1 | 2021 | 5 | 0.050 |
Why?
| | Analysis of Variance | 1 | 2004 | 1227 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2008 | 2194 | 0.050 |
Why?
| | Glycerides | 1 | 2019 | 15 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2007 | 3914 | 0.040 |
Why?
| | Epigenomics | 1 | 2020 | 105 | 0.040 |
Why?
| | Arachidonic Acids | 1 | 2019 | 58 | 0.040 |
Why?
| | Estradiol | 1 | 2002 | 452 | 0.040 |
Why?
| | Colorado | 1 | 2009 | 4116 | 0.040 |
Why?
| | Sex Factors | 1 | 2004 | 1737 | 0.040 |
Why?
| | L-Lactate Dehydrogenase | 1 | 1999 | 107 | 0.040 |
Why?
| | Drug Implants | 1 | 1998 | 71 | 0.040 |
Why?
| | omega-N-Methylarginine | 2 | 1994 | 25 | 0.040 |
Why?
| | Concanavalin A | 2 | 1994 | 75 | 0.040 |
Why?
| | Risk Factors | 3 | 2016 | 8699 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 1999 | 608 | 0.030 |
Why?
| | Mice, Neurologic Mutants | 1 | 1996 | 19 | 0.030 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 1996 | 30 | 0.030 |
Why?
| | Arginine | 2 | 1994 | 241 | 0.030 |
Why?
| | Anger | 1 | 2016 | 55 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2007 | 4668 | 0.030 |
Why?
| | DNA Methylation | 1 | 2020 | 498 | 0.030 |
Why?
| | Deoxyguanosine | 1 | 2015 | 26 | 0.030 |
Why?
| | Lung | 2 | 1999 | 3673 | 0.030 |
Why?
| | Mexico | 1 | 2016 | 163 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 1996 | 244 | 0.030 |
Why?
| | Trisomy | 1 | 1996 | 68 | 0.030 |
Why?
| | Arousal | 1 | 1996 | 153 | 0.030 |
Why?
| | Avoidance Learning | 1 | 1995 | 62 | 0.030 |
Why?
| | Transcriptome | 1 | 2020 | 736 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1994 | 198 | 0.030 |
Why?
| | Social Environment | 1 | 1996 | 286 | 0.030 |
Why?
| | Electroshock | 1 | 1994 | 140 | 0.030 |
Why?
| | Naltrexone | 1 | 1994 | 83 | 0.030 |
Why?
| | Parent-Child Relations | 1 | 2015 | 234 | 0.030 |
Why?
| | Proteins | 1 | 1999 | 920 | 0.030 |
Why?
| | Body Mass Index | 1 | 2020 | 1971 | 0.030 |
Why?
| | Parenting | 1 | 2015 | 254 | 0.030 |
Why?
| | Family | 1 | 2016 | 594 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1086 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2016 | 781 | 0.020 |
Why?
| | Infant, Low Birth Weight | 1 | 2012 | 125 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 6264 | 0.020 |
Why?
| | Cohort Studies | 1 | 2019 | 4945 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 959 | 0.020 |
Why?
| | Mental Disorders | 1 | 2016 | 902 | 0.020 |
Why?
| | United States | 2 | 2016 | 12297 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 4541 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 795 | 0.020 |
Why?
| | Mice | 1 | 1996 | 15052 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1994 | 1044 | 0.010 |
Why?
| | Immune Tolerance | 1 | 1994 | 332 | 0.010 |
Why?
|
|
Coussons-Read's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|